Antagonism of corticotropin-releasing factor attenuates the enhanced responsiveness to stress observed during protracted ethanol abstinence (Q44462759)

3 December 2017

Antagonism of corticotropin-releasing factor attenuates the enhanced responsiveness to stress observed during protracted ethanol abstinence (English)

1 reference

3 December 2017

4

George F Koob

1 reference

3 December 2017

Glenn R Valdez

1

1 reference

3 December 2017

Eric P Zorrilla

series ordinal

2

1 reference

3 December 2017

Amanda J Roberts

series ordinal

3

1 reference

3 December 2017

language of work or name

1 reference

1 February 2003

1 reference

3 December 2017

1 reference

3 December 2017

29

1 reference

3 December 2017

2

1 reference

3 December 2017

55-60

1 reference

Handling history of rats modifies behavioural effects of drugs in the elevated plus-maze test of anxiety.

3 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2803%2900020-X

7 January 2021

Gender in relation to relapse crisis situations, coping, and outcome among treated alcoholics.

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2803%2900020-X

7 January 2021

CRF antagonist reverses the "anxiogenic" response to ethanol withdrawal in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2803%2900020-X

7 January 2021

Persistence of a “subacute withdrawal syndrome” following chronic ethanol intake

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2803%2900020-X

7 January 2021

Activating and 'anxiogenic' effects of corticotropin releasing factor are not inhibited by blockade of the pituitary-adrenal system with dexamethasone

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2803%2900020-X

7 January 2021

Neurogenetic adaptive mechanisms in alcoholism

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2803%2900020-X

7 January 2021

Ethopharmacological analysis of rat behavior on the elevated plus-maze.

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2803%2900020-X

7 January 2021

Symptomatology in alcoholics at various stages of abstinence

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2803%2900020-X

7 January 2021

Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses?

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2803%2900020-X

7 January 2021

Chronic ethanol exposure potentiates the locomotor-activating effects of corticotropin-releasing factor (CRF) in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2803%2900020-X

7 January 2021

Anti-stress action of a corticotropin-releasing factor antagonist on behavioral reactivity to stressors of varying type and intensity

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2803%2900020-X

7 January 2021

Alcohol withdrawal symptoms and drinking behavior.

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2803%2900020-X

7 January 2021

Corticotropin-releasing factor, norepinephrine, and stress

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2803%2900020-X

7 January 2021

A role for corticotropin releasing factor and urocortin in behavioral responses to stressors.

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2803%2900020-X

7 January 2021

Drug abuse: hedonic homeostatic dysregulation

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2803%2900020-X

7 January 2021

Drug addiction, dysregulation of reward, and allostasis

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2803%2900020-X

7 January 2021

Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2803%2900020-X

7 January 2021

Decreased experimental anxiety and voluntary ethanol consumption in rats following central but not basolateral amygdala lesions.

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2803%2900020-X

7 January 2021

Effects of drugs on punished behavior: pre-clinical test for anxiolytics

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2803%2900020-X

7 January 2021

Microinjection of a corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal.

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2803%2900020-X

7 January 2021

In vivo CRF release in rat amygdala is increased during cocaine withdrawal in self-administering rats

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2803%2900020-X

7 January 2021

Hyperventilation, anxiety, craving for alcohol: a subacute alcohol withdrawal syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2803%2900020-X

7 January 2021

Effects of chronic ethanol exposure on oral self-administration of ethanol or saccharin by Wistar rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2803%2900020-X

7 January 2021

Effects of chronic ethanol exposure on neurophysiological responses to corticotropin-releasing factor and neuropeptide Y.

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2803%2900020-X

7 January 2021

Behavioral effects of central administration of the novel CRF antagonist astressin in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2803%2900020-X

7 January 2021

Increased ethanol self-administration and anxiety-like behavior during acute ethanol withdrawal and protracted abstinence: regulation by corticotropin-releasing factor

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2803%2900020-X

7 January 2021

Characterization of a 41-Residue Ovine Hypothalamic Peptide That Stimulates Secretion of Corticotropin and β-Endorphin

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2803%2900020-X

7 January 2021

Effects of antalarmin, a CRF type 1 receptor antagonist, on anxiety-like behavior and motor activation in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2803%2900020-X

7 January 2021

Changes in levels of regional CRF-like-immunoreactivity and plasma corticosterone during protracted drug withdrawal in dependent rats

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2803%2900020-X

7 January 2021

10.1016/S0741-8329(03)00020-X

Identifiers

DOI

1 reference

3 December 2017

1 reference